Market Overview:
The global next-generation neurofeedback devices market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for next-generation neurofeedback devices for various applications such as hospitals, clinics, ambulatory surgical centers, and others. Additionally, the rising awareness about the benefits of using next-generation neurofeedback devices is also contributing to the growth of this market. Some of the major players operating in this market are 3D Neuroimaging Ltd., BrainMaster Technologies Inc., Cambridge Brain Sciences Ltd., Cognionics Inc., Emotiv Systems Pty Ltd.
Product Definition:
Next-generation neurofeedback devices are devices that are used to help people improve their brain function. These devices use technology to help people learn how to control their brain waves. This can help people with conditions like ADHD, anxiety, and depression. The importance of these devices is that they can help people improve their brain function and better manage their mental health conditions.
Brand Name Next-Generation Neurofeedback Devices:
Next-generation neurofeedback devices are expected to be launched in the market during 2014 - 2025. The major drivers of this market include increasing prevalence of learning disabilities and attention deficit hyperactivity disorder (ADHD) as well as growing awareness about these devices among parents, physicians, and teachers. Furthermore, rising demand for home-based treatment is also anticipated to fuel the growth of this market during the forecast period.
3D Next-Generation Neurofeedback Devices:
3D NGNF devices are the advanced neurofeedback systems that provide real-time, on-site information about a patient's brain activity and performance.
Application Insights:
Neurofeedback devices are used for treating a variety of neurological disorders including anxiety, depression, ADHD, OCD and others. The others segment dominated the market in terms of revenue in 2017 due to the increasing adoption of neurofeedback devices for traumatic brain injury (TBI), post-concussion syndrome (PCS), and other neurological conditions. According to data published by Next Generation Neurofeedback Organization (NGNO) in 2018, NGNO is supporting over 40 clinical trials with more than 2000 patients across the globe.
The clinics segment is expected to witness lucrative growth during the forecast period owing to an increase in demand for neurotherapy among children diagnosed with attention deficit hyperactivity disorder (ADHD). In addition, growing awareness about these treatment options among parents as well as healthcare professionals will boost industry growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of favorable reimbursement policies, increasing prevalence of neurological disorders, and growing awareness about neurofeedback treatment are some factors attributing to the largest share. Moreover, a high number of FDA approvals for new devices is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising demand for technologically advanced products coupled with rapidly improving healthcare infrastructure in this region. Furthermore, an increase in awareness among people and rapid adoption of novel technologies are other factors contributing toward regional growth during the estimated time span.
Growth Factors:
- Increasing demand for better and more efficient treatment methods for various neurological disorders
- Growing awareness about the benefits of neurofeedback therapy
- Rising number of research studies supporting the efficacy of neurofeedback therapy
- Development of new and innovative neurofeedback devices
- Growing number of clinics offering neurofeedback therapy
Scope Of The Report
Report Attributes
Report Details
Report Title
Next-Generation Neurofeedback Devices Market Research Report
By Type
Brand Name Next-Generation Neurofeedback Devices, 3D Next-Generation Neurofeedback Devices
By Application
Hospitals, Clinics, Ambulatory Surgical Centers, Others
By Companies
Neurable, Looxid Labs, Neurotech International Ltd, ANT Neuro, BrainMaster Technologies, Inc., Neurogen Ltd, NeurOptimal, EEG Info
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Next-Generation Neurofeedback Devices Market Report Segments:
The global Next-Generation Neurofeedback Devices market is segmented on the basis of:
Types
Brand Name Next-Generation Neurofeedback Devices, 3D Next-Generation Neurofeedback Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Neurable
- Looxid Labs
- Neurotech International Ltd
- ANT Neuro
- BrainMaster Technologies, Inc.
- Neurogen Ltd
- NeurOptimal
- EEG Info
Highlights of The Next-Generation Neurofeedback Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Brand Name Next-Generation Neurofeedback Devices
- 3D Next-Generation Neurofeedback Devices
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Next-Generation Neurofeedback Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Next-generation neurofeedback devices are those that use more sophisticated technology to measure brainwave activity. They may include sensors that can detect different types of brainwaves, as well as a computer that can interpret the data and provide feedback to the user.
Some of the major companies in the next-generation neurofeedback devices market are Neurable, Looxid Labs, Neurotech International Ltd, ANT Neuro, BrainMaster Technologies, Inc., Neurogen Ltd, NeurOptimal, EEG Info.
The next-generation neurofeedback devices market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Next-Generation Neurofeedback Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Next-Generation Neurofeedback Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Next-Generation Neurofeedback Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Next-Generation Neurofeedback Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Next-Generation Neurofeedback Devices Market Size & Forecast, 2020-2028
4.5.1 Next-Generation Neurofeedback Devices Market Size and Y-o-Y Growth
4.5.2 Next-Generation Neurofeedback Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Brand Name Next-Generation Neurofeedback Devices
5.2.2 3D Next-Generation Neurofeedback Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Next-Generation Neurofeedback Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Next-Generation Neurofeedback Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Brand Name Next-Generation Neurofeedback Devices
9.6.2 3D Next-Generation Neurofeedback Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgical Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Brand Name Next-Generation Neurofeedback Devices
10.6.2 3D Next-Generation Neurofeedback Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgical Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Brand Name Next-Generation Neurofeedback Devices
11.6.2 3D Next-Generation Neurofeedback Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgical Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Brand Name Next-Generation Neurofeedback Devices
12.6.2 3D Next-Generation Neurofeedback Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgical Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Brand Name Next-Generation Neurofeedback Devices
13.6.2 3D Next-Generation Neurofeedback Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgical Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Next-Generation Neurofeedback Devices Market: Competitive Dashboard
14.2 Global Next-Generation Neurofeedback Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Neurable
14.3.2 Looxid Labs
14.3.3 Neurotech International Ltd
14.3.4 ANT Neuro
14.3.5 BrainMaster Technologies, Inc.
14.3.6 Neurogen Ltd
14.3.7 NeurOptimal
14.3.8 EEG Info
